Principal Investigator
Jose Lutzky
Enrollment Status
Closed
Clinical Trial ID
Institutional Protocol #
20250876
Clinical Trial Summary
Expanded Access use of IMDELLTRA in a 76-year-old pa_ent (SH) who was diagnosed with immunotherapy refractory DLL3+ Merkel cell carcinoma
Phase
Approved Drug/Off-Label use
Funding Agency/Sponsor
Institutional
Disease
Cutaneous Malignancies
Contact Information
Phone Number
305-243-2647